The TIF-1γ autoantigen in patients with dermatomyositis and thyroid cancer: from case series to preliminary mechanistic exploration
Open Access
- 8 September 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1817558
Abstract
Objectives: This study aimed to explore the relationship between dermatomyositis (DM) and thyroid cancer and the role of transcriptional intermediary factor 1γ (TIF-1γ) in the pathogenesis of cancer-associated DM. Methods: Five cases of DM with thyroid cancer, including one with metastasis, were summarized and analyzed. Published cases of DM with thyroid cancer were reviewed. Subsequently, a bidirectional two-sample Mendelian randomization (MR) analysis was performed to investigate the relationship between thyroid cancer and myositis using inverse-variance weighting (IVW), MR-Egger, and weighted-median (WM) analyses. Finally, immunohistochemistry (IHC) and immunofluorescence (IF) analysis were performed to detect TIF-1γ in tumor tissues of a DM patient and a thyroid cancer patient without DM. Results: This article reports the first case of a patient with DM and metastatic papillary thyroid carcinoma (PTC), in whom recurrence of the rash prompted the detection of metastasis, with the rash resolving after surgical resection of the metastatic foci. MR analysis showed a potential causal relationship between thyroid cancer and myositis (OR = 1.398; 95% CI = 1.045–1.869; p = 0.029). A higher expression level of TIF-1γ was observed in tumor tissues of DM patients compared with those of thyroid cancer patients without DM by immunofluorescence (IF) analysis ( p < 0.0001). Conclusions: DM symptoms might represent a paraneoplastic phenomenon in patients with thyroid cancer, with the underlying pathological mechanisms requiring further exploration and TIF-1γ overexpression potentially serving as a trigger.Keywords
This publication has 28 references indexed in Scilit:
- Innovation in DermatomyositisDermatologic Clinics, 2024
- Dermatomyositis - key to diagnosing ovarian cancer, monitoring treatment and detecting recurrent disease: Case reportGynecologic Oncology Reports, 2018
- Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2015
- Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgeryGynecologic Oncology Case Reports, 2013
- Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteinsArthritis & Rheumatism, 2011
- Malignancy in MyositisCurrent Rheumatology Reports, 2011
- Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?Rheumatology International, 2009
- Dermatomyositis associated with thyroid cancerRheumatology International, 2008
- A novel autoantibody to a 155‐kd protein is associated with dermatomyositisArthritis & Rheumatism, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006